Business Context and Reporting Period
This Form 8-K Current Report was filed by AmerisourceBergen Corporation (now Cencora, Inc.) on May 12, 2020. The filing discloses a significant capital market transaction involving the pricing of new senior notes and the entry into an underwriting agreement.
Key Financial Metrics and Transaction Details
- New Debt Issuance: Priced $500 million aggregate principal amount of 2.800% Senior Notes due May 15, 2030.
- Net Proceeds: Estimated at approximately $493.8 million after deducting underwriting discounts and offering expenses.
- Use of Proceeds: Intended to redeem all outstanding 3.500% Senior Notes due November 15, 2021, and for general corporate purposes.
- Existing Credit Facilities: As of March 31, 2020, there were no borrowings outstanding under the multi-currency revolving credit facility. The receivables securitization facility had $350 million outstanding.
Material Changes and Transaction Structure
The primary material change is the refinancing of existing debt. The company entered into an Underwriting Agreement with BofA Securities, Inc., MUFG Securities Americas Inc., and U.S. Bancorp Investments, Inc. The sale of the new notes is expected to close on May 19, 2020, subject to standard closing conditions. The new notes are senior unsecured obligations registered under a shelf registration statement filed in November 2018.
Outlook, Risks, and Management Commentary
Management indicated that pending the application of net proceeds, the company expects to invest funds in high-quality, short-term debt securities. The filing includes extensive forward-looking statements and risk factors, highlighting significant uncertainties including:
- COVID-19 Impact: Risks related to financial market volatility, supplier/customer insolvency, and changes to payment terms.
- Regulatory and Legal: Ongoing opioid litigation, federal and state enforcement initiatives regarding controlled substances, and potential changes in healthcare reimbursement.
- Operational: Risks associated with the strategic relationship with Walgreens Boots Alliance, Inc., and potential impairment of goodwill.
Investor Verification Checklist
- Confirm the closing of the $500 million note issuance on or around May 19, 2020.
- Verify the successful redemption of the 3.500% Senior Notes due November 2021 using the new proceeds.
- Monitor the status of the multi-district opioid litigation and related legal reserves.
- Assess the impact of COVID-19 on customer payment terms and supplier stability as noted in the risk factors.
- Review the final terms of the Underwriting Agreement filed as Exhibit 1.1 for specific covenants and conditions.